Physician profile
David B Essaff
NPI 1558627083
$536.86
in general payments reported to CMS, 2019-2025
9 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.84 · 2020: $62.31 · 2021: $50.39 · 2023: $127 · 2024: $78.46 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $274.78 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Avanos Medical | $95.47 | 2019-2023 | Coolief* Cooled Radiofrequency |
| Medtronic, INC. | $39.02 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Globus Medical, INC. | $29.66 | 2025 | Senza |
| Merz Pharmaceuticals, LLC | $29.02 | 2023 | Xeomin |
| Abbott Laboratories | $19.78 | 2024 | Proclaim |
| Relievant Medsystems, INC. | $18.86 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.37 | 2025 | Iovera |
| Collegium Pharmaceutical, INC. | $13.90 | 2025 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Essaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.